{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T11:56:08Z","timestamp":1793447768835,"version":"4.5.0"},"reference-count":41,"publisher":"Bentham Science Publishers Ltd.","issue":"1","license":[{"start":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:00:00Z","timestamp":1672963200000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/legalcode"}],"funder":[{"DOI":"10.13039\/100016079","name":"Major Science and Technology Special Project of Xinjiang Uygur Autonomous Region","doi-asserted-by":"publisher","award":["2020A03004"],"award-info":[{"award-number":["2020A03004"]}],"id":[{"id":"10.13039\/100016079","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program","doi-asserted-by":"publisher","award":["2017YFC0907200"],"award-info":[{"award-number":["2017YFC0907200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program","doi-asserted-by":"publisher","award":["2017YFC0907203"],"award-info":[{"award-number":["2017YFC0907203"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CCHTS"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Pulmonary tuberculosis (PTB) is a significant risk factor for COPD, and Xinjiang,\nChina, has a high incidence of pulmonary tuberculosis. The effects of tuberculosis history on\nairflow restriction, clinical symptoms, and acute episodes in COPD patients have not been reported\nin the local population. Besides, the exact relationship between lung function changes in people\nwith a history of tuberculosis and COPD risk is not clear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This study is based on the Xinjiang baseline survey data included in the Natural Population\nCohort Study in Northwest China from June to December, 2018. Subjects' questionnaires,\nphysical examination, and lung function tests were performed through a face-to-face field survey to\nanalyze the impact of previous pulmonary tuberculosis on local COPD. Furthermore, we clarified\nthe specific relationship between pulmonary function decline and the probability of developing\nCOPD in people with a history of tuberculosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 3249 subjects were eventually enrolled in this study, including 87 with a history\nof tuberculosis and 3162 non-TB. The prevalence of COPD in the prior TB group was significantly\nhigher than that in the control group (p-value = 0.005). First, previous pulmonary tuberculosis is an\nessential contributor to airflow limitation in the general population and patients with COPD. In all\nsubjects included, pulmonary function, FEV1% predicted (p-value &lt; 0.001), and FEV1\/FVC (%)\n(p-value &lt; 0.001) were significantly lower in the prior TB group than in the control group. Compared\nto non-TB group, FEV1% prediction (p-value = 0.019) and FEV1\/FVC (%) (p-value\n= 0.016) were found to be significantly reduced, and airflow restriction (p-value = 0.004) was more\nsevere in prior TB group among COPD patients. Second, COPD patients in the prior TB group had\nmore severe clinical symptoms. Compared with no history of tuberculosis, mMRC (p-value\n= 0.001) and CAT (p-value = 0.002) scores were higher in the group with a history of tuberculosis\namong COPD patients. Third, compared with the non-TB group, the number of acute exacerbations\nper year (p-values\uff1d0.008), the duration of each acute exacerbation (p-values\uff1d0.004), and hospitalization\/\npatient\/year (p-values\uff1c0.001) were higher in the group with a history of tuberculosis\namong COPD patients. Finally, a dose-response relationship between FEV1\/FVC (%) and the\nprobability of developing COPD in people with previous pulmonary TB was observed; when\nFEV1\/FVC (%) was &lt; 80.8, the risk of COPD increased by 13.5% per unit decrease in lung function\n[0.865(0.805, 0.930)].<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>COPD patients with previous pulmonary tuberculosis have more severe airflow limitations\nand clinical symptoms and are at higher risk for acute exacerbations. Furthermore, lung\nfunction changes in people with a history of tuberculosis were associated with a dose-response relationship\nwith the probability of developing COPD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1386207325666220406111435","type":"journal-article","created":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T06:59:01Z","timestamp":1649314741000},"page":"93-102","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Impact of Previous Pulmonary Tuberculosis on Chronic Obstructive Pulmonary\nDisease: Baseline Results from a Prospective Cohort Study"],"prefix":"10.2174","volume":"26","author":[{"given":"Yide","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Integrated Pulmonology, The Traditional Chinese Medicine Hospital Affiliated to Xinjiang Medical\nUniversity, Urumqi, 830000, P.R. China"},{"name":"National Clinical Research Base of Traditional Chinese Medicine in Xinjiang,\nUrumqi, 830000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Integrated Pulmonology, The Traditional Chinese Medicine Hospital Affiliated to Xinjiang Medical\nUniversity, Urumqi, 830000, P.R. China"},{"name":"National Clinical Research Base of Traditional Chinese Medicine in Xinjiang,\nUrumqi, 830000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8012-3769","authenticated-orcid":true,"given":"Fengsen","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Integrated Pulmonology, The Traditional Chinese Medicine Hospital Affiliated to Xinjiang Medical\nUniversity, Urumqi, 830000, P.R. China"},{"name":"National Clinical Research Base of Traditional Chinese Medicine in Xinjiang,\nUrumqi, 830000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.26719\/emhj.18.014","volume":"25","author":"Varmaghani M.","year":"2019","unstructured":"Varmaghani M.; Dehghani M.; Heidari E.; Sharifi F.; Moghaddam S.S.; Farzadfar F.; Global prevalence of chronic obstructive pulmonary disease: Systematic review and meta-analysis. East Mediterr Health J 2019,25(1),47-57","journal-title":"East Mediterr Health J"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S0140-6736(09)61290-3","volume":"374","author":"Soriano J.B.","year":"2009","unstructured":"Soriano J.B.; Zielinski J.; Price D.; Screening for and early detection of chronic obstructive pulmonary disease. Lancet 2009,374(9691),721-732","journal-title":"Lancet"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/S0140-6736(18)30841-9","volume":"391","author":"Wang C.","year":"2018","unstructured":"Wang C.; Xu J.; Yang L.; Xu Y.; Zhang X.; Bai C.; Kang J.; Ran P.; Shen H.; Wen F.; Huang K.; Yao W.; Sun T.; Shan G.; Yang T.; Lin Y.; Wu S.; Zhu J.; Wang R.; Shi Z.; Zhao J.; Ye X.; Song Y.; Wang Q.; Zhou Y.; Ding L.; Yang T.; Chen Y.; Guo Y.; Xiao F.; Lu Y.; Peng X.; Zhang B.; Xiao D.; Chen C.S.; Wang Z.; Zhang H.; Bu X.; Zhang X.; An L.; Zhang S.; Cao Z.; Zhan Q.; Yang Y.; Cao B.; Dai H.; Liang L.; He J.; Prevalence and risk factors of chronic obstruc-tive pulmonary disease in China (the China Pulmonary Health [CPH] study): A national cross-sectional study. Lancet China Pulmonary Health Study Group2018,391(10131),1706-1717","journal-title":"Lancet"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.clnu.2016.07.008","volume":"36","author":"Hoong J.M.","year":"2017","unstructured":"Hoong J.M.; Ferguson M.; Hukins C.; Collins P.F.; Econom-ic and operational burden associated with malnutrition in chronic obstructive pulmonary disease. Clin Nutr 2017,36(4),1105-1109","journal-title":"Clin Nutr"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.2147\/COPD.S222581","volume":"14","author":"Viinanen A.","year":"2019","unstructured":"Viinanen A.; Lassenius M.I.; Toppila I.; Karlsson A.; Veijalainen L.; Id&#xE4;np&#xE4;n-Heikkil&#xE4; J.J.; Laitinen T.; The bur-den of chronic obstructive pulmonary disease (COPD) in Fin-land: Impact of disease severity and eosinophil count on healthcare resource utilization. Int J Chron Obstruct Pulmon Dis 2019,14,2409-2421","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1177\/0269216320940153","volume":"34","author":"Luckett T.","year":"2020","unstructured":"Luckett T.; San Martin A.; Currow D.C.; Johnson M.J.; Barnes-Harris M.M.; Phillips J.L.; A systematic review and meta-analysis of studies comparing burden from lung cancer and chronic obstructive pulmonary disease. Palliat Med 2020,34(10),1291-1304","journal-title":"Palliat Med"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1183\/09031936.00083507","volume":"30","author":"Menezes A.M.B.","year":"2007","unstructured":"Menezes A.M.B.; Hallal P.C.; Perez-Padilla R.; Jardim J.R.; Mui&#xF1;o A.; Lopez M.V.; Valdivia G.; Montes de Oca M.; Talamo C.; Pertuze J.; Victora C.G.; Latin American Project for the Investigation of Obstructive Lung Disease (PLATINO) Team. Tuberculosis and airflow obstruction: Evidence from the PLATINO study in Latin America. Eur Respir J 2007,30(6),1180-1185","journal-title":"Eur Respir J"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1378\/chest.09-1435","volume":"137","author":"Lam K.B.","year":"2010","unstructured":"Lam K.B.; Jiang C.Q.; Jordan R.E.; Miller M.R.; Zhang W.S.; Cheng K.K.; Lam T.H.; Adab P.; Prior T.B.; Prior TB, smoking, and airflow obstruction: A cross-sectional analysis of the Guangzhou Biobank Cohort Study. Chest 2010,137(3),593-600","journal-title":"Chest"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nrmicro2236","volume":"7","author":"Barry C.E.","year":"2009","unstructured":"Barry C.E.; Boshoff H.I.; Dartois V.; Dick T.; Ehrt S.; Flynn J.; Schnappinger D.; Wilkinson R.J.; Young D.; The spectrum of latent tuberculosis: Rethinking the biology and intervention strategies. Nat Rev Microbiol 2009,7(12),845-855","journal-title":"Nat Rev Microbiol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"e32103","DOI":"10.1371\/journal.pone.0032103","volume":"7","author":"Qi Y-C.","year":"2012","unstructured":"Qi Y-C.; Ma M-J.; Li D-J.; Chen M-J.; Lu Q-B.; Li X-J.; Li J-L.; Liu W.; Cao W-C.; Multidrug-resistant and exten-sively drug-resistant tuberculosis in multi-ethnic region, Xin-jiang Uygur Autonomous Region, China. PLoS One 2012,7(2),e32103","journal-title":"PLoS One"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.2147\/COPD.S155675","volume":"13","author":"Matheson M.C.","year":"2018","unstructured":"Matheson M.C.; Bowatte G.; Perret J.L.; Lowe A.J.; Sena-ratna C.V.; Hall G.L.; de Klerk N.; Keogh L.A.; McDonald C.F.; Waidyatillake N.T.; Sly P.D.; Jarvis D.; Abramson M.J.; Lodge C.J.; Dharmage S.C.; Prediction models for the development of COPD: A systematic review. Int J Chron Obstruct Pulmon Dis 2018,13,1927-1935","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"477","DOI":"10.2147\/COPD.S297380","volume":"16","author":"Wang Y.","year":"2021","unstructured":"Wang Y.; Li Z.; Li F.S.; Development and assessment of prediction models for the development of COPD in a typical rural area in northwest China. Int J Chron Obstruct Pulmon Dis 2021,16,477-486","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.rmed.2014.10.015","volume":"109","author":"Jo Y.S.","year":"2015","unstructured":"Jo Y.S.; Choi S.M.; Lee J.; Park Y.S.; Lee S-M.; Yim J-J.; Yoo C-G.; Kim Y.W.; Han S.K.; Lee C-H.; The relationship between chronic obstructive pulmonary disease and comor-bidities: A cross-sectional study using data from KNHANES 2010-2012. Respir Med 2015,109(1),96-104","journal-title":"Respir Med"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"2004026","DOI":"10.1183\/13993003.04026-2020","volume":"58","author":"Satia I.","year":"2021","unstructured":"Satia I.; Priel E.; Al-Khazraji B.K.; Jones G.; Freitag A.; O\u2019Byrne P.M.; Killian K.J.; Exercise-induced bronchocon-striction and bronchodilation: Investigating the effects of age, sex, airflow limitation and FEV1. Eur Respir J 2021,58(2),2004026","journal-title":"Eur Respir J"},{"key":"ref=15","first-page":"3","volume":"11","author":"Lange P.","year":"2016","unstructured":"Lange P.; Halpin D.M.; O\u2019Donnell D.E.; MacNee W.; Diag-nosis, assessment, and phenotyping of COPD: Beyond FEV\u2081 Int J Chron Obstruct Pulmon Dis 2016,11(Spec Iss),3-12","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"e0193880","DOI":"10.1371\/journal.pone.0193880","volume":"13","author":"Huang W-C.","year":"2018","unstructured":"Huang W-C.; Wu M-F.; Chen H-C.; Hsu J-Y.; Consortium T.O.L.D.; Characteristics and risk factors for inconsistency between the risk of exacerbations and the severity of airflow limitation in COPD based on GOLD 2017: A retrospective, cross-sectional study. PLoS One Taiwan Obstructive Lung Disease Consortium2018,13(3),e0193880","journal-title":"PLoS One"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jfma.2018.06.018","volume":"118","author":"Cheng S-L.","year":"2019","unstructured":"Cheng S-L.; Lin C-H.; Wang C-C.; Chan M-C.; Hsu J-Y.; Hang L-W.; Perng D-W.; Yu C-J.; Wang H-C.; Taiwan Clini-cal Trial Consortium for Respiratory Disease (TCORE). Com-parison between COPD assessment test (CAT) and modified medical research council (mMRC) dyspnea scores for evalua-tion of clinical symptoms, comorbidities and medical re-sources utilization in COPD patients. J Formos Med Assoc 2019,118(1 Pt 3),429-435","journal-title":"J Formos Med Assoc"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1111\/resp.12780","volume":"21","author":"Ko F.W.","year":"2016","unstructured":"Ko F.W.; Chan K.P.; Hui D.S.; Goddard J.R.; Shaw J.G.; Reid D.W.; Yang I.A.; Acute exacerbation of COPD. Respirology 2016,21(7),1152-1165","journal-title":"Respirology"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1183\/13993003.02325-2014","volume":"46","author":"Amaral A.F.","year":"2015","unstructured":"Amaral A.F.; Coton S.; Kato B.; Tan W.C.; Studnicka M.; Janson C.; Gislason T.; Mannino D.; Bateman E.D.; Buist S.; Burney P.G.; Tuber-culosis associates with both airflow obstruction and low lung function: BOLD results. Eur Respir J BOLD Collaborative Research Group2015,46(4),1104-1112","journal-title":"Eur Respir J"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/resp.13147","volume":"23","author":"Park H.J.","year":"2018","unstructured":"Park H.J.; Byun M.K.; Kim H.J.; Ahn C.M.; Kim D.K.; Kim Y.I.; Oh J.Y.; Yoon H.K.; Yoo K.H.; Jung K.S.; Histo-ry of pulmonary tuberculosis affects the severity and clinical outcomes of COPD. Respirology 2018,23(1),100-106","journal-title":"Respirology"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"e0116832","DOI":"10.1371\/journal.pone.0116832","volume":"10","author":"Zheng Y-L.","year":"2015","unstructured":"Zheng Y-L.; Zhang L-P.; Zhang X-L.; Wang K.; Zheng Y-J.; Forecast model analysis for the morbidity of tuberculosis in Xinjiang, China. PLoS One 2015,10(3),e0116832","journal-title":"PLoS One"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12879-016-2152-4","volume":"17","author":"Maimaiti R.","year":"2017","unstructured":"Maimaiti R.; Zhang Y.; Pan K.; Mijiti P.; Wubili M.; Musa M.; Andersson R.; High prevalence and low cure rate of tu-berculosis among patients with HIV in Xinjiang, China. BMC Infect Dis 2017,17(1),15","journal-title":"BMC Infect Dis"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"e0187592","DOI":"10.1371\/journal.pone.0187592","volume":"12","author":"He X.","year":"2017","unstructured":"He X.; Cao M.; Mahapatra T.; Du X.; Mahapatra S.; Li Q.; Feng L.; Tang S.; Zhao Z.; Liu J.; Tang W.; Burden of tu-berculosis in Xinjiang between 2011 and 2015: A surveillance data-based study. PLoS One 2017,12(11),e0187592","journal-title":"PLoS One"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1900164","DOI":"10.1183\/13993003.00164-2019","volume":"53","author":"Singh D.","year":"2019","unstructured":"Singh D.; Agusti A.; Anzueto A.; Barnes P.J.; Bourbeau J.; Celli B.R.; Criner G.J.; Frith P.; Halpin D.M.G.; Han M.; L&#xF3;pez Varela M.V.; Martinez F.; Montes de Oca M.; Papi A.; Pavord I.D.; Roche N.; Sin D.D.; Stockley R.; Vestbo J.; Wedzicha J.A.; Vogelmeier C.; Global strategy for the di-agnosis, management, and prevention of chronic obstructive lung disease: The GOLD science committee report 2019. Eur Respir J 2019,53(5),1900164","journal-title":"Eur Respir J"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.5334\/aogh.2418","volume":"85","author":"Perez-Padilla R.","year":"2019","unstructured":"Perez-Padilla R.; Menezes A.M.B.; Chronic obstructive pul-monary disease in Latin America. Ann Glob Health 2019,85(1),7","journal-title":"Ann Glob Health"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1136\/thorax.55.1.32","volume":"55","author":"Hnizdo E.","year":"2000","unstructured":"Hnizdo E.; Singh T.; Churchyard G.; Chronic pulmonary function impairment caused by initial and recurrent pulmo-nary tuberculosis following treatment. Thorax 2000,55(1),32-38","journal-title":"Thorax"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1148\/radiographics.21.4.g01jl06839","volume":"21","author":"Kim H.Y.","year":"2001","unstructured":"Kim H.Y.; Song K-S.; Goo J.M.; Lee J.S.; Lee K.S.; Lim T-H.; Thoracic sequelae and complications of tuberculosis. Radiographics 2001,21(4),839-858","journal-title":"Radiographics"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/MCP.0b013e32835cfff5","volume":"19","author":"Holloway R.A.","year":"2013","unstructured":"Holloway R.A.; Donnelly L.E.; Immunopathogenesis of chronic obstructive pulmonary disease. Curr Opin Pulm Med 2013,19(2),95-102","journal-title":"Curr Opin Pulm Med"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/nri2448","volume":"8","author":"Mosser D.M.","year":"2008","unstructured":"Mosser D.M.; Edwards J.P.; Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008,8(12),958-969","journal-title":"Nat Rev Immunol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.7150\/ijms.51654","volume":"18","author":"Fu J.","year":"2021","unstructured":"Fu J.; Lu L.; Wang H.; Hou Y.; Dou H.; Hirsutella sinensis mycelium regulates autophagy of alveolar macrophages via TLR4\/NF-&#x3BA;B signaling pathway. Int J Med Sci 2021,18(8),1810-1823","journal-title":"Int J Med Sci"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1172\/JCI72030","volume":"124","author":"Nouailles G.","year":"2014","unstructured":"Nouailles G.; Dorhoi A.; Koch M.; Zerrahn J.; Weiner J.; Fa&#xE9; K.C.; Arrey F.; Kuhlmann S.; Bandermann S.; Loewe D.; Mollenkopf H.J.; Vogelzang A.; Meyer-Schwesinger C.; Mittr&#xFC;cker H.W.; McEwen G.; Kaufmann S.H.; CXCL5-secreting pulmonary epithelial cells drive de-structive neutrophilic inflammation in tuberculosis. J Clin Invest 2014,124(3),1268-1282","journal-title":"J Clin Invest"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1165\/rcmb.2019-0209OC","volume":"63","author":"Kalchiem-Dekel O.","year":"2020","unstructured":"Kalchiem-Dekel O.; Yao X.; Barochia A.V.; Kaler M.; Figueroa D.M.; Karkowsky W.B.; Gordon E.M.; Gao M.; Fergusson M.M.; Qu X.; Liu P.; Li Y.; Seifuddin F.; Pirooznia M.; Levine S.J.; Apolipoprotein E signals via TLR4 to induce CXCL5 secretion by asthmatic airway epithelial cells. Am J Respir Cell Mol Biol 2020,63(2),185-197","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12890-019-0939-y","volume":"19","author":"Li Z.","year":"2019","unstructured":"Li Z.; Mao X.; Liu Q.; Song H.; He B.; Shi P.; Zhang Q.; Li X.; Wang J.; Functional variations of the TLR4 gene in as-sociation with chronic obstructive pulmonary disease and pulmonary tuberculosis. BMC Pulm Med 2019,19(1),184","journal-title":"BMC Pulm Med"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1164\/ajrccm.156.1.9612018","volume":"156","author":"Finlay G.A.","year":"1997","unstructured":"Finlay G.A.; O\u2019Driscoll L.R.; Russell K.J.; D\u2019Arcy E.M.; Masterson J.B.; FitzGerald M.X.; O\u2019Connor C.M.; Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med 1997,156(1),240-247","journal-title":"Am J Respir Crit Care Med"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"4657","DOI":"10.1128\/AAC.02141-13","volume":"58","author":"Singh S.","year":"2014","unstructured":"Singh S.; Kubler A.; Singh U.K.; Singh A.; Gardiner H.; Prasad R.; Elkington P.T.; Friedland J.S.; Antimycobacterial drugs modulate immunopathogenic matrix metalloproteinases in a cellular model of pulmonary tuberculosis. Antimicrob Agents Chemother 2014,58(8),4657-4665","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"30211","DOI":"10.1074\/jbc.M110.167031","volume":"286","author":"Patrick G.","year":"2011","unstructured":"Patrick G.; Abdoulaye J.D.; D\u2019Armiento J.; TLR4 protein contributes to cigarette smoke-induced matrix metalloprotein-ase-1 (MMP-1) expression in chronic obstructive pulmonary disease. J Biol Chem 2011,286(34),30211-30218","journal-title":"J Biol Chem"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1741-7015-11-181","volume":"11","author":"Wedzicha J.A.","year":"2013","unstructured":"Wedzicha J.A.; Brill S.E.; Allinson J.P.; Donaldson G.C.; Mechanisms and impact of the frequent exacerbator pheno-type in chronic obstructive pulmonary disease. BMC Med 2013,11(1),181","journal-title":"BMC Med"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"170103","DOI":"10.1183\/16000617.0103-2017","volume":"27","author":"Viniol C.","year":"2018","unstructured":"Viniol C.; Vogelmeier C.F.; Exacerbations of COPD. Eur Respir Rev 2018,27(147),170103","journal-title":"Eur Respir Rev"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1479972318769762","DOI":"10.1177\/1479972318769762","volume":"16","author":"Titova E.","year":"2019","unstructured":"Titova E.; Christensen A.; Henriksen A.H.; Steinshamn S.; &#xC5;sberg A.; Comparison of procalcitonin, C-reactive protein, white blood cell count and clinical status in diagnosing pneu-monia in patients hospitalized with acute exacerbations of COPD: A prospective observational study. Chron Respir Dis 2019,16,1479972318769762","journal-title":"Chron Respir Dis"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.2147\/COPD.S106160","volume":"11","author":"Hillas G.","year":"2016","unstructured":"Hillas G.; Perlikos F.; Tzanakis N.; Acute exacerbation of COPD: Is it the &#x201C;stroke of the lungs&#x201D;? Int J Chron Obstruct Pulmon Dis 2016,11,1579-1586","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","volume":"363","author":"Hurst J.R.","year":"2010","unstructured":"Hurst J.R.; Vestbo J.; Anzueto A.; Locantore N.; M&#xFC;llerova H.; Tal-Singer R.; Miller B.; Lomas D.A.; Agusti A.; Mac-nee W.; Calverley P.; Rennard S.; Wouters E.F.; Wedzicha J.A.; Evaluation of COPD longitudinally to identify predictive surrogate endpoints (ECLIPSE) investigators. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010,363(12),1128-1138","journal-title":"N Engl J Med"}],"container-title":["Combinatorial Chemistry &amp; High Throughput Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1386207325666220406111435","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/203180\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1386207325666220406111435","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T10:52:15Z","timestamp":1702637535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/203180\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1386207325666220406111435","relation":{},"ISSN":["1386-2073"],"issn-type":[{"value":"1386-2073","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-09-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-30","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}